Related references
Note: Only part of the references are listed.Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism
Matthias Koenig et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy
Robert A. Rizza
DIABETES (2010)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes
Safina Ali et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects
Susanne Lerche et al.
CLINICAL ENDOCRINOLOGY (2009)
Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism
Ananda Basu et al.
DIABETES CARE (2009)
Insulin Therapy for Type 2 Diabetes
Sanne G. Swinnen et al.
DIABETES CARE (2009)
Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys
Hai Yan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant?
Frank Q. Nuttall et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus
F. K. Knop et al.
DIABETOLOGIA (2007)
Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey
Kamran Akram et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus
Z Israelian et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
The effect of rosiglitazone on the liver: Decreased gluconeogenesis in patients with type 2 diabetes
A Gastaldelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
HJ Woerle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus
E Henkel et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Glucagon as a target for the treatment of Type 2 diabetes
KW Sloop et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Drug therapy: Insulin analogues
IB Hirsch
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia
KB Degn et al.
DIABETES (2004)
Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes
R Basu et al.
DIABETES (2004)
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes
M Krssak et al.
DIABETES (2004)
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes
SA Segel et al.
DIABETES (2002)
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients
A Gastaldelli et al.
DIABETES (2001)
Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus
A Wajngot et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Share Paper
